Despite the evident significance of these early, non-neuronal disease mechanisms, the majority of biomarker research for MSA has been concentrated on alpha-synuclein, in addition to different markers of neuronal degeneration and catecholamines [4]. The gene discussed is SNCA; the disease is multiple system atrophy.